Tag Archives: Research

Pressemitteilungen

CodeCheck: Oeeda erweitert Management mit Head of Science

Ex-Procter & Gamble-Managerin Ruta Almedom leitet neuen Marktforschungsbereich der CodeCheck AG

Berlin/Zürich, 11.04.2019 – Original Pressemitteilung Oeeda (www.oeeda.com), der neue Marktforschungsbereich der CodeCheck AG hat heute die Ernennung von Ruta Almedom zur neuen Head of Science bekannt gegeben. Ruta Almedom wird ab sofort die Leitung der wissenschaftlichen Abteilung der CodeCheck AG übernehmen. CodeCheck (www.codecheck.info) ist Anbieter des gleichnamigen führenden Einkaufsratgebers für Lebensmittel und Kosmetika im deutschsprachigen Raum und gilt als „eines der renommiertesten Portale, wenn es um Auskünfte über Inhaltsstoffe geht“ (Neue Zürcher Zeitung). Almedom folgt auf Mandy Hecht, welche die Leitung des Marktforschungsbereichs Oeeda verantwortet.

Almedom kommt von Procter & Gamble, wo sie in den vergangenen zehn Jahren als Senior Scientist im Bereich Produktforschung für verschiedene Gruppen des Konzerns tätig war. Ruta Almedom spezialisierte sich auf Neurobiologie, Molekularbiologie und Biochemie und promovierte an der Johann Wolfgang Goethe-Universität in Frankfurt am Main.

„Die beliebte CodeCheck-App wird bereits von Millionen moderner Verbraucherinnen und Verbraucher genutzt, die gesunde und nachhaltigkeitsorientierte Lebensstile bevorzugen, Mikroplastik vermeiden wollen oder sich laktosefrei oder glutenfrei ernähren müssen. Zukünftige Märkte und Innovationen kommen an dieser stark wachsenden Zielgruppe nicht mehr vorbei und CodeCheck stellt mit Oeeda einen einmaligen Kanal zur Kommunikation zwischen Herstellern und bewussten Konsumenten her“, erklärt Dr. Ruta Almedom.

„Mit Erkenntnissen aus der CodeCheck-Community bieten wir FMCG-Herstellern und Marketing-Entscheidern umfangreiche, spezialisierte und schnelle Marktforschungs-Dienstleistungen wie zum Beispiel die neuen „Oeeda Category Reports“. Hierfür ist die Einhaltung sehr hoher Qualitätsstandards notwendig, die unsere wissenschaftliche Abteilung sicherstellt. Wir freuen uns sehr, dass wir Ruta Almedom mit ihrer langjährigen Expertise für diese anspruchsvolle Aufgabe gewinnen konnten“, erläutert Dr. Mandy Hecht, Leiterin des Oeeda-Produktbereichs.

Oeeda ist der neue Marktforschungsbereich der CodeCheck AG, Anbieter der CodeCheck-App, dem beliebten Einkaufsratgeber für bewusste Konsumenten im deutschsprachigen Raum mit über 2,5 Millionen registrierten Nutzerinnen und Nutzern. Die CodeCheck-App wird von führenden Medien immer wieder empfohlen.

Hochauflösendes Presse-Bildmaterial zur honorarfreien Nutzung unter:http://bit.ly/Oeeda-New_Head_of_Science-Mediakit

Über OeedaOeeda (www.oeeda.com) ist der neue B2B-Marktforschungsbereich der CodeCheck AG, Anbieter des führenden Einkaufsratgebers für Lebensmittel und Kosmetika im deutschsprachigen Raum mit über 2,5 Millionen registrierten Nutzerinnen und Nutzern. Oeeda bietet FMCG-Herstellern, Marketing-Entscheidern und dem Einzelhandel umfangreiche, spezialisierte und schnelle Marktforschung-Dienstleistungen im Zusammenhang mit der stark wachsenden Zielgruppe der bewussten Konsumentinnen und Konsumenten (z.B. vegane und vegetarische Lebensstile, Verzicht auf laktose- und glutenhaltige Lebensmittel). Beliebte Produkte sind die „Oeeda Category Reports“ mit direkten Verbraucheranalysen, qualitatives Verbraucher-Feedback zu mehreren Millionen Produkten und das derzeit umfangreichste Panel bewusster Konsumenten im DACH-Raum für viele Anwendungsbereiche – von Design-Tests bis zu klassischen mobilen Umfragen.

CodeCheck App Download:Apple iOS: https://itunes.apple.com/de/app/codecheck-lebensmittel-kosmetik/id359351047

Google Android: https://play.google.com/store/apps/details?id=ch.ethz.im.codecheck

Unternehmenskontakt Oeeda:
CodeCheck AG
Unternehmenskommunikation
Joachim M. Guentert
Jenatschstrasse 1
CH-8002 Zürich
Tel.: +41 44 450 25 41
E-Mail: joachim.guentert@codecheck.info

Oeeda ( www.oeeda.com) ist der neue B2B-Marktforschungsbereich der CodeCheck AG, Anbieter des führenden Einkaufsratgebers für Lebensmittel und Kosmetika im deutschsprachigen Raum mit über 2,5 Millionen registrierten Nutzerinnen und Nutzern.

Oeeda bietet FMCG-Herstellern, Marketing-Entscheidern und dem Einzelhandel umfangreiche, spezialisierte und schnelle Marktforschung-Dienstleistungen im Zusammenhang mit der stark wachsenden Zielgruppe der bewussten Konsumentinnen und Konsumenten (z.B. vegane und vegetarische Lebensstile, Verzicht auf laktose- und glutenhaltige Lebensmittel).

Beliebte Produkte sind die „Oeeda Category Reports“ mit direkten Verbraucheranalysen, qualitatives Verbraucher-Feedback zu mehreren Millionen Produkten und das derzeit umfangreichste Panel bewusster Konsumenten im DACH-Raum für viele Anwendungsbereiche – von Design-Tests bis zu klassischen mobilen Umfragen.

Kontakt
CodeCheck AG
Joachim Guentert
Jenatschstrasse 1
8002 Zürich
+41 44 450 25 41
joachim.guentert@codecheck.info
http://www.codecheck.info

Die Bildrechte liegen bei dem Verfasser der Mitteilung.

Internationales Pressemitteilungen

Interventional Radiology Products Market worth $8.02 Billion by 2021 | Know The Key Market Drivers

According to a new market research report „Interventional Radiology Products Market by type (Stents, Catheters, IVC Filter, Accessories), Procedure Type (Angioplasty, Angiography, Biopsy, Thrombolysis, Embolization), Applications (Oncology, Cardiology, Urology & Nephrology) – Forecast to 2021“, published by MarketsandMarkets, the global market is expected to reach USD 8.02 Billion by 2021 from USD 6.35 Billion in 2016, at a CAGR of 4.8% from 2016 to 2021.

Don’t miss out on business opportunities in Interventional Radiology Products Market. Speak to our analyst and gain crucial industry insights that will help your business grow:
https://www.marketsandmarkets.com/speaktoanalyst.asp?id=67681703

The major factors driving the growth of this market are rising incidence of chronic diseases, rising geriatric population, and increasing demand for minimally invasive surgeries. However, new players in the interventional radiology sector face significant entry barriers; this is a key challenge in the market.

Based on type, the market is segmented into stents, catheters, IVC filters, hemodynamic flow alteration devices, angioplasty balloons, thrombectomy systems, embolization devices, biopsy needles, and accessories. In 2016, the stents segment is expected to dominate the global interventional radiology products market. The key factors driving the growth of the interventional radiology stents market are the growing geriatric population and increasing incidence of cardiovascular diseases around the world.

Browse and in-depth TOC on “ Interventional Radiology Products Market

79 – Tables
37 – Figures
144 – Pages

View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/interventional-radiology-product-market-67681703.html Based on procedure, the market is segmented into angioplasty, angiography, embolization, thrombolysis, biopsy & drainage, vertebroplasty, nephrostomy, and other applications. In 2016, the angiography segment is expected to account for the largest share of this market. The growing demand for minimally invasive procedures and increasing geriatric population are the key factors in this segment.

Based on region, the global interventional radiology products market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). In 2016, North America is expected to account for the largest share of the market. The rising incidence of chronic diseases (CVD), the increasing demand for minimally invasive procedures, and availability of reimbursement for minimally invasive products in this region are the major factors contributing to the growth of this market.

Request for Free Sample Report @ https://www.marketsandmarkets.com/requestsample.asp?id=67681703

Key players in the interventional radiology products market include Abbott Vascular (US), Boston Scientific Corporation (US), Medtronic plc (Ireland), Cardinal Health (US), B. Braun Melsungen AG (Germany), CR Bard (US), Biosensor International Group Ltd. (Singapore), Stryker Corporation (US), Terumo Corporation (Japan), and Cook Medical Inc. (US).

Browse Adjacent Markets @ Medical Devices Market Research Reports & Consulting

About MarketsandMarkets ™

MarketsandMarkets ™ provides quantified B2B research on 30,000 high growth opportunities / threats 70% to 80% of worldwide companies‘ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets ™ for their painpoints around

Our 850 fulltime analyst and SMEs at MarketsandMarkets ™ are following the „Growth Engagement Model – GEM“. The GEM aims to identify new opportunities, identify the most important customers, write attack, avoid and defend strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets ™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets ™ is going to spend more than 10,000 companies this year for their revenue planning and help them make their innovations / disruptions early to the market.

MarketsandMarkets‘ flagship competitive intelligence and market research platform, ‚Knowledge Store‘, joins over 200,000 markets and entire value chains for the understanding of the marketplace.

Contact:

Mr. Shelly Singh
MarketsandMarkets ™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
United States: 1-888-600-6441
Email: sales@marketsandmarkets.com

Aktuelle Nachrichten Internationales Pressemitteilungen

Increasing Prevalence of Chronic Diseases Driving Growth In Enteral Feeding Devices Market

According to a new market research Enteral Feeding Devices Market by Type (Feeding Pump, Feeding Tube, Giving Set, Enteral Syringes), Age Group (Adult, Pediatric), Application (Oncology, Gastroenterology, Diabetes), End User (Hospital, Home Care) – Global Forecast to 2022″, published by MarketsandMarkets™, the market is expected to reach USD 3.19 Billion by 2022 from an estimated USD 2.39 Billion in 2017, at a CAGR of 6.0% during the forecast period.

Browse 281 market data Tables and 48 Figures spread through 304 Pages and in-depth TOC on „Enteral Feeding Devices Market“.

Factors such as the increasing prevalence of chronic diseases, rising geriatric population, rising incidence of preterm births, growing demand for enteral feeding devices in the home care sector, and the shift from parenteral to enteral nutrition are the key drivers of the Enteral Feeding Devices Market. Furthermore, the rising demand for user-friendly feeding devices and technological advancements are contributing to the growth of this market. However, the complications associated with the use of enteral feeding devices and the insufficient reimbursements for enteral nutrition are some of the major challenges currently at play in the market.

By product, the enteral feeding pumps segment accounted for the largest share of the market

On the basis of products, the enteral feeding pumps segment accounted for the largest share of the Enteral Feeding Devices Market, in 2016. This can be attributed to the low risk of complications with the use of feeding pumps, enhanced portable pump designs, and the increasing use of pumps in home care settings.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownload.asp?id=183623035

The adults segment dominated the market in 2016

Based on age group, the adults segment accounted for the largest share of the Enteral Feeding Devices Market. The large share can be attributed to the increasing incidence and prevalence of chronic diseases like cancer, diabetes, neurological disorders, and inflammatory bowel syndrome that result in malnutrition along with the rapid rise in the aging population.

The oncology segment is expected to grow at the highest CAGR during the forecast period

By application, the Enteral Feeding Devices Market is segmented into oncology, gastroenterology, diabetes, neurology, hyper metabolism, and other applications. The oncology segment is expected to grow at the highest CAGR owing to the increasing incidence and prevalence of cancer across the globe and the need for clinical nutrition in such patients.

North America dominated the market in 2016

North America accounted for the largest share of the Enteral Feeding Devices Market in 2016, followed by Europe. This regional segment shows significant market growth opportunities owing to the high adoption of enteral feeding devices, increasing prevalence of chronic diseases, presence of many large hospitals, and the development of innovative products. Moreover, a number of major global players are based in the US.

The prominent players in the Enteral Feeding Devices Market are Fresenius Kabi (Germany), Halyard Health (US), Medtronic (Ireland), B. Braun (Germany), Abbott (US), C.R. Bard (US), Boston Scientific (US), Cook Medical (US), CONMED (US), Nestlé (Switzerland), Danone (France), Moog (US), Vygon (France), and Applied Medical Technology (US).

Medical Devices Market Research Reports & Consulting

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies‘ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the „Growth Engagement Model – GEM“. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write „Attack, avoid and defend“ strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, „Knowledge Store“ connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Shelly Singh

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA: +1-888-600-6441

Email: sales@marketsandmarkets.com

Research Insight: https://www.marketsandmarkets.com/ResearchInsight/enteral-feeding-device-market.asp

Pressemitteilungen

www.biolitec.com: New website presents modern medical laser therapies

biolitec® has launched a new website – Functional modern design – Worldwide leading developer and manufacturer of minimally invasive laser therapies – Successful research and development in areas such as phlebology and proctology – 10 years ELVeS®

www.biolitec.com: New website presents modern medical laser therapies

biolitec®_Homepage_en (Source: @biolitec biomedical technology gmbh)

Jena, May 22, 2018 – The developer and manufacturer of medical laser systems for minimally-invasive therapies, biolitec biomedical technology GmbH, has unveiled its new online presence. A modern layout now stands for an adapted innovative website functionality and a better overview of the company’s versatile product and application areas: Thanks to the new tile design, the entire website is structured in a way that the extensive range of medical applications and laser systems of biolitec® can be recognized at first glance.

This principle of fast recognition can be found both in the subject area for doctors and for patients. This, for instance, gives doctors an immediate overview of all biolitec® lasers. For example, if the visitor clicks on the „Dual 100“ tile, he can, due to the simple depiction, see all the therapeutic areas in which this laser can be used.

The same applies to patients: The respective therapy subpages under the menu item „patients“ lead directly to the patient websites adapted to the special needs of patients, such as www.info-varicose-vein.com, which can also be accessed as independent websites.

Founded more than 30 years ago, biolitec® has become one of the world’s leading companies in the field of minimally invasive laser therapies – due to continuous research and development of its products. Thanks to subsidiaries, including in South America and Asia, its innovative laser systems and methods are available for a wide range of applications for gentle and low-intensity treatment options all around the globe. biolitec® lasers are often innovative alternatives to conventional treatment methods in phlebology, proctology, thoracic surgery, urology, gynecology, ENT and orthopedics.

For 10 years now, the unique ELVeS® Radial® 2-ring laser fiber of biolitec®, with its efficient and simple technology, has been convincing in the treatment of varicose veins.

As a result of intensive research, biolitec® has always been able to offer the most modern possibilities in minimally invasive laser medicine. The new LEONARDO® laser family by biolitec® includes the only laser systems available on the market in which two wavelengths can be adjusted and used independently and continuously during the treatment. The universal applicability of the lasers in various fields of application is unique.

Further information on all products and applications of the laser therapies by biolitec® is available directly on the new website www.biolitec.com.

About biolitec
biolitec® is one of the world“s leading medical technology companies in the field of laser applications and the only provider which possesses all the relevant core competences in the field of photodynamic therapy (PDT) – photosensitizers, lasers and fibre optic cables. Besides laser-supported treatment of cancers with the drug Foscan®, biolitec® researches and markets above all minimally invasive, gentle laser procedures.
ELVeS® Radial® (Endo Laser Vein System) is the world“s most-used laser system to treat venous insufficiency. The LEONARDO® diode laser from biolitec® is the first universally applicable medical laser which has a combination of two wavelengths, 980nm and 1470nm, and which can be used across disciplines. The innovative contact fibre XCAVATOR® in conjunction with the LEONARDO® DUAL 200 Watt laser allows in urology a gentle treatment of e.g. benign prostate enlargement (BPH). The light-weight LEONARDO® Mini laser weighing only 900 g was developed especially for mobile application on site. Gentle laser applications in the fields of proctology, ENT, gynecology, thorax surgery and pneumology are also part of biolitec®“s field of business. More information available at www.biolitec.com

Contact
biolitec biomedical technology GmbH
Joern Gleisner
Otto-Schott-Str. 15
07745 Jena
Phone: +49 (0) 3641 / 51953-36
Fax: +49 (0) 6172 / 27159-69
E-Mail: joern.gleisner@biolitec.com
Url: http://www.biolitec.com

Aktuelle Nachrichten Auto/Verkehr Computer/Internet/IT Energie/Natur/Umwelt Essen/Trinken Finanzen/Wirtschaft Gesellschaft/Politik Gesundheit/Medizin Pressemitteilungen Reisen/Tourismus

Global Oligonucleotide Synthesis Market – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024

 

 

Global Oligonucleotide Synthesis Market: By Product (Synthesized oligonucleotides, Reagents, Equipment), By Application (Diagnostics, Research, Therapeutics), By End-Users (Diagnostic Laboratories, Research Institutes, Biotechnology & Pharmaceutical Companies), and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024

 

Global oligonucleotide synthesis market was valued at US $ XX Mn and expected to grow at XX% Compound Annual Growth Rate (CAGR) over 2018 to 2024.

 

Market Outline: Oligonucleotide Synthesis Market

Oligonucleotide Synthesis is synthesis of short fragments of the nucleic acids which has a defined chemical structure. This process of chemical synthesis enables provide a rapid access to the custom-made oligonucleotides. The building blocks are coupled sequentially which further helps in growing the customized oligonucleotide chain.

 

Market Dynamics: Oligonucleotide Synthesis Market

The increase in adoption of advanced technologies are expected to increase the growth of oligonucleotide synthesis market. The surge in initial investments in research and development, companies focused on novel technologies are anticipated to fuel the growth of oligonucleotide synthesis market. Furthermore, these R&D activities are adding scope for the advent of new products which is likely to enhance the growth of the oligonucleotide synthesis market, providing opportunities to the manufactures. The increasing government support in developing technologies such as the oligonucleotide synthesis technology and the genomic technologies is enriching the growth of the market. Personalized medicine is playing a vital role, expected to add fuel for the growth of oligonucleotide synthesis market. However, the stringent government regulations in approval of oligonucleotide-based therapeutics are expected to hamper the growth of the market.

 

Free sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/oligonucleotide-synthesis-market/#ulp-4H8Z4LpNMLEuOnnx

 

Market Scope: Oligonucleotide Synthesis Market

Oligonucleotide synthesis market is segmented based on the product, application, and end-user

Based on the product, the market is segmented into the following:

  • Synthesized oligonucleotides
    • DNA oligonucleotides
    • RNA oligonucleotides
    • Others
  • Reagents
  • Equipment

Based on the application, the market is segmented into the following:

  • Diagnostics
  • Research
  • Therapeutics

Based on the end-user, the market is segmented into the following:

  • Diagnostic Laboratories
  • Research Institutes
  • Biotechnology & Pharmaceutical Companies

 

Free TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/oligonucleotide-synthesis-market/#ulp-c654SbFYO64MsOhu

 

Regional Analysis:  Oligonucleotide Synthesis Market

Geographically, global oligonucleotide synthesis market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America oligonucleotide synthesis market is dominant and is expected to hold its position over the forecasted period. The soaring advancements in the healthcare sector, increased investments in biotechnology is expected to witness the growth of the market. The increasing R&D activities, sophisticated infrastructure expected to fuel the market. The Asia Pacific oligonucleotide synthesis market is expected to accelerate the growth in the forecasted period owing to emerging economies such as China and India, which enables increase the growth of oligonucleotide synthesis market.

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/oligonucleotide-synthesis-market/#ulp-14mlyhjMGhVjZqa3

 

Competition Assessment: Oligonucleotide Synthesis Market

Some of the players in the global oligonucleotide synthesis market include:

  • Thermo Fisher Scientific Inc. (U.S)
  • Integrated DNA Technologies, Inc. (U.S)
  • Sigma-Aldrich Corporation (U.S)
  • GE Healthcare (U.S)
  • Eurofins Genomics (Germany)
  • Nitto Denko Avecia Inc. (Japan)
  • Agilent Technologies Inc. (U.S)

Notable Market Developments: Oligonucleotide Synthesis Market

  • In October 2017, Integrated DNA Technologies has acquired oligonucleotide manufacturing business of GeneWorks Pty Ltd. (GeneWorks) in Australia.

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/oligonucleotide-synthesis-market/

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US):+1-866-598-1553

Website @https://www.precisionbusinessinsights.com

 

 

 

 

 

Computer/Internet/IT Gesundheit/Medizin Pressemitteilungen Telekommunikation Wissenschaft/Forschung

Diese 4 Anwendungen zeigen das Potenzial von Big Data und Medizin

Potenzial von Big Data

Big-Data-Technologien erlauben es, aus enormen Datenbergen in kürzester Zeit neueste Erkenntnisse zu gewinnen. Lesen Sie weiters, welche Vorteile Big Data spezifisch in der Medizin bietet.  Erfahren Sie anhand von 4 Beispielen mehr über das riesige Potenzial von Big Data. read more »

Pressemitteilungen

Brussels, May 23: Scientific Conference epiXchange2018

Seven large EU-funded projects have joined forces – epiXchange 2018 brings together Europe’s best brains to pave the way for future epilepsy research.

Brussels, May 23: Scientific Conference epiXchange2018

Scientific Conference epiXchange 2018, May 23, 2018, Brussels

Around 50 million people worldwide suffer from epilepsy, making it one of the most common neurological diseases. To decrease this figure and pave the way for future ground-breaking epilepsy research, seven large EU-funded projects have joined forces. epiXchange 2018 is a unique global community building event, designed to gather a critical mass of epilepsy researchers to exchange about latest progress in research aiming to improve the way epilepsy is diagnosed and treated and thereby increase the quality of life of affected people. Six of these projects were funded through the 7th Framework Programme (FP7) which provided total funding of EUR 52 million.

Despite a great progress in the management of epilepsy, 30-40% of epilepsy patients are refractory to all available medications.
Moreover, about 50% of children with epilepsy suffer from epilepsy-related co-morbidities, including developmental delay, learning disabilities, and autism spectrum disorder. Diagnostics is another issue.
„Diagnosis of epilepsy is really difficult,“ explained Prof. David Henshall, coordinator of the epiXchange 2018 co-organising EpimiRNA project. „Seizures are the main clinical symptom for the disease but it is very rare that a doctor will witness the patient having a seizure.“

New innovative solutions to diagnose and treat epilepsy

As published in HORIZON – The EU Research & Innovation Magazine on February 12, one of the major results from the epiXchange projects is the development of biomarkers for epilepsy diagnosis. Identifying biomarkers and changes to brain structures may ultimately lead to new treatments.
„Combining biomarkers is key,“ said Prof. Merab Kokaia, coordinator of the co-organising EPITARGET project. „It could make treatment more personalised in the years to come. Another interesting result as published in HORIZON on April 6 is the fact that delaying epilepsy onset through preventive medication in children with related disorders could reduce the impact on development of epilepsy and other related symptoms.
„If you have a brain malformation… there is nothing you can do to revers it. But… if you can prevent epilepsy from aggravating the situation you can improve the clinical status of these patients“, said Renzo Guerrini, coordinator of the co-organising DESIRE project.
Efforts have been made to pin down the genetics behind the disorders. Blood samples of babies at four key moments – at birth, when the EEG first begins to pick up problems, when seizures begin and at two years of age may help us to develop new drugs.
„We have a very, very unique situation. For the first time we have access to the molecular story before epilepsy“, said Prof. Sergiusz Jozwiak, coordinator of the co-organising EPISTOP project.

These findings and many others will be showcased at epiXchange. To boost the impact of the event, the epiXchange partners are preparing a white paper, presenting the current state of the art in epilepsy research, major bottlenecks and recommendations to shape the way for further research breakthroughs, to move forward to new ways of treatment and to bring research results closer to clinical application.

Five major areas

The epiXchange 2018 scientific conference focuses on five major themes in epilepsy research:

Genetics:
Development of novel treatment strategies based on optogenetics, gene and stem cell therapies.

Therapeutics:
Development of effective epileptogenic therapeutics, many of which face different kinds of bottlenecks e.g. regulatory hurdles.

Biomarkers:
Identification of new biomarkers in blood, peripheral organs, brain tissue, electrophysical data, behavioural data and imaging data, in order to develop novel preventive strategies in at-risk patients.

Biobanks and databases:
Integration of Biobanks and databases into clinical care to facilitate preclinical research. A collaborative approach as foundation for the future of epilepsy research and other disease model biobanks.

Co-morbidities:
Exploration of the mechanisms underlying bi-directional relations between epilepsy and neurological co-morbidities to reduce the high burden of co-morbidities in epilepsy.

epiXchange 2018 is is a dissemination activity of the FP7 funded projects DESIRE, EpimiRNA, EpiTarget and EPISTOP and is open for scientists, EC representatives, industries and other stakeholders from the epilepsy community as well as the press.

epiXchange 2018 key data
Organisers: DESIRE, EpimiRNA, EPISTOP and EpiTarget; Scientific contributions by EpiCare, EpiPGX and Epixchange
Venue: THE EGG, Brussels, www.theeggbrussels.com
Date: May 23, 2018
Homepage: www.epiXchange2018.eu
Twitter: www.twitter.com/epiXchange
Facebook: www.facebook.com/epiXchange2018/

Seven large EC-funded projects on epilepsy co-organise this conference to disseminate project results and discuss the future of epilepsy research in the EU and worldwide.

Six of these projects were funded through the 7th Framework Programme (FP7) which provided total funding of EUR 52 million.

Four of the projects (DESIRE, EpimiRNA, EPISTOP and EpiTarget), still ongoing FP7 collaborative research projects, are co-financing the event. Scientific contributions are provided by partners from EpiCare, an ongoing reference network project, as well as EpiPGX (FP7 collaborative research project) and Epixchange (FP7 MSCA ITN project), which are now finished.

Contact
ARTTIC S.A.S
Sebastian Vinzenz Gfäller
Oskar-von-Miller-Ring 29
80333 München
Phone: +49-89 248 83 03 -36
E-Mail: gfaeller@arttic.eu
Url: http://www.arttic.eu

Pressemitteilungen

Fingerprint Sensors Market | Research Growth by Manufacturers, Regions, Type and Application, Forecast Analysis to 2018-2026 by Acumen Research and Consulting

„Fingerprint Sensors Market „ is the latest addition to Acumen Research and Consulting industry research reports collection.

This research study on the Global Fingerprint Sensors Market offers detailed and insightful information on major regional markets and related sub-markets. The information is gathered via both, but not limited to, extensive secondary research and primary research. The major secondary data sources referred for collecting information include industry journals, white papers, databases, company reports, and up-to-date press releases among others. The study also comprises factors driving and inhibiting the development of fingerprint sensors market. The key opportunity areas and trends prevalent in this market are also been compiled in this study. The current size of this market and its predicted market size by the end of forecast period have been highlighted through this study.

Download Table of Content@ https://www.acumenresearchandconsulting.com/tentative-table-of-content/478

The report has been studied in terms of key market segments and sub-segments. The information on currently leading market segments and sub-segments and the reasons for this growth have been emphasized in the scope of this study. An extensive analysis of fingerprint sensors market has been encapsulated on the basis of estimations of key market segments in the forecast horizon. In addition, the technological developments that took place in the market and those predicted to take place in coming years have also been outlined through this study.

The projections presented in this study on fingerprint sensors market have been made by analyzing market’s future potential and prevalent trends. The market’s growth in various geographies has been studied in detail under this report. The top regions in this market and the reasons for the growth in that particular region have been outlined in the report. Further, the report presents competitive landscape of the fingerprint sensors market, covering information on the market share/positioning analysis of leading players in the market. Under this section, the prime strategies of key players, their strengths and weaknesses, and contributions in market growth are discussed. These players are also evaluated on the basis of attributes such as revenue, gross, product overview, and contact information.

Report Coverage

Market Fingerprint Sensors Market
Analysis Period 2014 – 2024
Historic Data 2014 – 2015
Base Year 2016
Forecast Data 2017 – 2024
Market Stratification Type, Application, Material, Sensor Technology, Geography
Regional Scope North America, Europe, Asia-Pacific, Latin America, Middle East and Africa (MEA)
Report Coverage Market Trends, Drivers, Restraints, Porter’s Five Forces Analysis, Competitive Analysis, Player Profiling, Value Chain Analysis

Our expert team will assist and customize the report so that it best fit your exact requirement, Click Here@ https://www.acumenresearchandconsulting.com/request-customization/478

The major market segments of global fingerprint sensors market are as below:

Market By Type

Swipe sensor

Touch sensor

Area sensor

Market By Application

Law enforcement

Banking & finance

Mobile devices

Government, military & defense

Others

Market By Material

Optical prism

Sapphire

Adhesive

Piezoelectric material

Others

Market By Sensor Technology

Capacitive sensor

o Passive capacitance

o Active capacitance

Optical sensor

Ultrasonic sensor

Thermal sensor

Others

Market By Geography

North America

o US

o Canada

o Mexico

Europe

o UK

o Germany

o France

o Rest of Europe

Asia-Pacific

o China

o Japan

o India

o Australia

o Rest of Asia-Pacific

Latin America

o Brazil

o Rest of Latin America

Middle East and Africa (MEA)

o South Africa

o Saudi Arabia

o Rest of MEA

Market Players

The fingerprint sensor market is distinguished by low competition and various application areas. The major players operating in the global fingerprint sensor market include IDEX ASA, Fingerprint Cards AB, Synaptics Incorporated, Vkansee Technology Inc., Cross Match Holdings, Inc., and Integrated Biometrics, Inc among others. Countries such as the U.S., U.K., China, Germany, and South Korea hold large market share in the fingerprint sensor market. Also, there are numerous collaborations occurring between mobile device and fingerprint sensor manufacturers.

Inquiry Before Buying@ https://www.acumenresearchandconsulting.com/inquiry-before-buying/478

Buy this premium research report@ https://www.acumenresearchandconsulting.com/buy-now/0/478

Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com

About Us

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.

Pressemitteilungen

plentymarkets bei ERP des Jahres-Verleihung ausgezeichnet

Doppelte Auszeichnung für E-Commerce Dienstleister

plentymarkets bei ERP des Jahres-Verleihung ausgezeichnet

In einer jährlich stattfindenden Preisverleihung unter der Leitung von Prof. Dr. Gronau vom Center of Enterprise Research der Uni Potsdam werden fortschrittliche und innovative ERP (kurz für Enterprise Resource Planning) Systeme ausgezeichnet. Dabei werden die ausgewählten ERP-Anbieter, die sich durch ihre Lösungen und Leistungen für die Auszeichnung qualifizieren, von einer Experten-Jury bewertet.

Als einziger Teilnehmer konnte der nordhessische E-Commerce-Dienstleister plentymarkets bei der diesjährigen Verleihung am 18. Oktober 2017 gleich zwei Urkunden mit nach Hause nehmen: Zum einen gelangte das Unternehmen als Finalist unter die besten drei 3 der Kategorie „Cloudbasierte Systeme“, und zusätzlich wurde plentymarkets aufgrund seiner besonderen Eignung für aufstrebende kleine und auch mittelständische Unternehmen der KMU-Sonderpreis verliehen.

Besonderes Augenmerk auf Kundennutzen

Die Preisverleihung fand im Rahmen des diesjährigen ERP-Kongresses im Frankfurter Sheraton Airport Hotel statt. Die nominierten Unternehmen mussten mit einer Präsentation und anschließender offenen Fragerunde die 3-köpfige Jury überzeugen. Krönender Abschluss der zweitägigen Veranstaltung war schließlich die Preisverleihung in den verschiedenen Kategorien. Moderiert wurde die Verleihung von TV-Journalistin Anja Kohl und Prof. Dr. Norbert Gronau.

Bei der Bewertung der ERPs wurden die ausgewählten Systeme von den Experten der Jury in Bezug auf die Kriterien „Kundenkommunikation“, „Forschung und Entwicklung“, „Spezifische Funktionen“, „Ergonomie“, „Technologie und Integrationsumfang“, „Einführungsmethodik“ und „Konkreter Kundennutzen“ intensiv geprüft. Den beiden letztgenannten Kriterien wurde dabei eine besondere Gewichtung beigemessen, wodurch deutlich wird, welch großen Wert Jury auf die Praxisnähe der zu bewertenden ERPs legte.

Umfangreiche Software für anspruchsvolle Händler

plentymarkets überzeugte die Experten mit seinem großen und durch Plugins erweiterbaren Funktionsumfang, durch den Händler ihren kompletten Vertrieb effizient über die Cloud-basierte Plattform managen können. So stehen plentymarkets Kunden neben einem eigenen Webshop auch Anbindungen zu sämtlichen relevanten nationalen und internationalen Online-Marktplätzen sowie ein Kassensystem für den stationären Handel als Vertriebsmöglichkeiten zur Verfügung. Ein zentrales Warenwirtschaftssystem sorgt dafür, dass Überbuchungen vermieden werden können und Anwender jederzeit den vollen Überblick über ihre Warenbestände haben.

Besonderes Augenmerk legte die Jury auch auf die Möglichkeit, mit plentymarkets eine Vielzahl von Aufgaben und Prozessen zu automatisieren. Anwendern werden auf diese Weise viele kleinschrittige Arbeiten softwareseitig abgenommen.

Eine erweiterungsfähige Architektur sorgt dafür, dass das plentymarkets System erweitert und individuellen Bedürfnissen angepasst werden kann: so lassen sich beliebig viele weitere Möglichkeiten wie etwa neue Marktplätze oder Sonderfunktionen unkompliziert per Plugin in plentymarkets integrieren.

Auf dem richtigen Weg zur bestmöglichen E-Commerce-Lösung

Bei plentymarkets ist die Freude über die doppelte Platzierung groß: „Wir sind hoch motiviert, die bestmögliche Lösung für den E-Commerce anbieten zu können. Die Auszeichnung durch das Center for Enterprise Research ist ein großartiges Zeichen dafür, dass wir auf dem richtigen Weg sind.“, so Jan Griesel, CEO und Gründer von plentymarkets.

plentymarkets ist ein E-Commerce ERP-System, das Warenwirtschaft mit Shopsystem und Multi-Channel-Vertrieb verbindet. Die umfangreichen Funktionen und Schnittstellen der online-basierten Software entlang der gesamten E-Commerce-Wertschöpfungskette ermöglichen einen vollumfänglichen und hochgradig automatisierten Workflow im Online-Handel. plentymarkets bietet neben dem eigenen Webshop Anbindungen zu allen relevanten Marktplätzen, Payment-, Logistik-, Webshop-, Recht- und Affiliate-Marketing-Anbietern und ermöglicht Händlern so auf einfache Weise, eine Vielzahl an Verlaufskanälen gleichzeitig zu erschließen. Dank konsequenter Prozessautomatisierung versetzt plentymarkets Händler in die komfortable Lage, Zeit und Kosten in erheblichem Umfang einzusparen und die eigene Wettbewerbsfähigkeit zu steigern.

Firmenkontakt
plentymarkets GmbH
Heidi Pfannes
Bürgermeister-Brunner-Str. 15
34117 Kassel
+49 (0) 561 – 98 681 100
redaktion@plentymarkets.com
http://www.plentymarkets.com

Pressekontakt
plentymarkets GmbH
Kathrin Langmann
Bürgermeister-Brunner-Str. 15
34117 Kassel
0561/98 681 243
redaktion@plentymarkets.com
http://www.plentymarkets.com

Versicherung/Vorsorge

Targeting UK Mass Affluents with Insurance Industry Segments, Growth Prospects: Radiant Insights, Inc

The mass affluent population in the UK is growing, meaning the demographic is an opportunity for providers selling personal insurance. Mass affluents are more likely to be male, have higher household incomes, and be married compared to retail customers. The assets of mass affluents are higher value, making their insurance needs more complex. They have different lifestyles compared to retail customers, meaning they also have different insurance needs. They travel abroad more often, and are more likely to own a second home, a car that requires specialist insurance, and high-value items that require additional cover. The penetration of personal insurance products is higher among mass affluents than retail customers, and they also pay higher premiums.

Key Findings

– Mass affluent customers are likely to only purchase a policy once they are confident in the provider and the product offered, making sure that all options and repercussions have been explored.
– Mass affluents are traditional buyers who want guidance and a more personal experience when buying cover.
– Customer loyalty is high for mass affluents. 76.0% stayed with their existing provider in 2016.
– Provider reputation and personal recommendations are more important to mass affluents than retail customers.
Synopsis

„Targeting UK Mass Affluents with Insurance“ report explores the differing attitudes and insurance needs of higher affluence customers in comparison to the mass market. It explores the demographics of the group, the products they hold, and their purchasing preferences. It also highlights the leading providers for mass affluents, and discusses the opportunities and best ways providers can reach and engage with this customer group.

Reasons To Buy

– To understand the differing needs of mass affluent customers in comparison to the mass market.
– To improve customer engagement by recognizing what is most important to mass affluent customers and how insurers can adapt their products and services to meet their needs.
– To discover the top providers within the mass affluent insurance market.
– To explore the opportunities the mass affluent market provides in terms of insurance innovation.